These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 31207293

  • 1. G-CSF-Mobilized Blood and Bone Marrow Grafts as the Source of Stem Cells for HLA-Identical Sibling Transplantation in Patients with Thalassemia Major.
    Li Q, Luo J, Zhang Z, Liu L, Luo L, Yang G, Liu R, Shi L, Huang R, Wu M, Lai Y.
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2040-2044. PubMed ID: 31207293
    [Abstract] [Full Text] [Related]

  • 2. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
    Wen J, Haque Q, Pei F, Chen L, Ruan Y, Liu X, He Y, Feng X, Li C, Wu X.
    Acta Haematol; 2018 Oct; 140(1):20-29. PubMed ID: 30071526
    [Abstract] [Full Text] [Related]

  • 3. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q, Liu H, Liang X, Yang T, Fan Z, Huang F, Ling Y, Liao X, Xuan L, Xu N, Xu X, Ye J, Liu Q.
    J Hematol Oncol; 2017 Jul 04; 10(1):135. PubMed ID: 28676100
    [Abstract] [Full Text] [Related]

  • 4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 04; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 5. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug 04; 33(8):610-4. PubMed ID: 23134851
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN, Wu DP, Wang Y, Qiu HY, Jin ZM, Miao M, Tang XW, Fu ZZ, Ma X, Han Y, He GS, Chen SN, Xue SL, Zhao Y.
    Ai Zheng; 2006 Aug 04; 25(8):1019-22. PubMed ID: 16965686
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I, Rowe JM, Khalil A, Ben-Arush M, Elhasid R.
    Biol Blood Marrow Transplant; 2016 Jun 04; 22(6):1043-1048. PubMed ID: 27016193
    [Abstract] [Full Text] [Related]

  • 8. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF.
    JAMA; 2014 Jul 02; 312(1):48-56. PubMed ID: 25058217
    [Abstract] [Full Text] [Related]

  • 9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW.
    Biol Blood Marrow Transplant; 2017 Sep 02; 23(9):1498-1508. PubMed ID: 28554856
    [Abstract] [Full Text] [Related]

  • 10. Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
    Wang HX, Yan HM, Wang ZD, Xue M, Liu J, Guo ZK.
    Leuk Lymphoma; 2012 Apr 02; 53(4):654-9. PubMed ID: 21929286
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
    Lee KH, Lee JH, Lee JH, Kim DY, Park HS, Choi EJ, Ko SH, Seol M, Lee YS, Kang YA, Jeon M, Baek S, Kang YL, Kim SH, Yun SC, Kim H, Jo JC, Choi Y, Joo YD, Lim SN.
    Biol Blood Marrow Transplant; 2017 Sep 02; 23(9):1555-1566. PubMed ID: 28552421
    [Abstract] [Full Text] [Related]

  • 13. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
    Sun L, Wang N, Chen Y, Tang L, Xing C, Lu N, Shi Y, Ma Y, Lin F, Yu K, Feng J.
    Biol Blood Marrow Transplant; 2019 Aug 02; 25(8):1592-1596. PubMed ID: 30951841
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR, Ji SQ, Wang HX, Yan HM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug 02; 10(4):340-6. PubMed ID: 12513770
    [Abstract] [Full Text] [Related]

  • 15. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
    Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ.
    Biol Blood Marrow Transplant; 2002 Aug 02; 8(5):261-7. PubMed ID: 12064363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT.
    Wang K, Lv M, Chang YJ, Zhao XY, Zhao XS, Zhang YY, Sun YQ, Wang ZD, Suo P, Zhou Y, Liu D, Zhai SZ, Hong Y, Wang Y, Zhang XH, Xu LP, Liu KY, Huang XJ.
    J Hematol Oncol; 2019 Mar 18; 12(1):31. PubMed ID: 30885244
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, Vermont C, Ahmad I, Shaw PJ, Telles da Cunha JM, Schlegel PG, Hough R, Fasth A, Kentouche K, Gruhn B, Fernandes JF, Lachance S, Bredius R, Resnick IB, Belohradsky BH, Gennery A, Fischer A, Gaspar HB, Schanz U, Seger R, Rentsch K, Veys P, Haddad E, Albert MH, Hassan M, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation.
    Lancet; 2014 Feb 01; 383(9915):436-48. PubMed ID: 24161820
    [Abstract] [Full Text] [Related]

  • 20. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F, Ostronoff M, Souto-Maior AP, Domingues M, Sucupira A, Manso DA, de Lima AK, Monteiro PG, Florêncio R, Calixto R.
    Clin Transplant; 2009 Feb 01; 23(1):33-8. PubMed ID: 18727660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.